Acadia Pharmaceuticals to announce Q2 2026 results on August 4
Acadia Pharmaceuticals Inc. will release its Q2 2026 financial results on August 4, 2026, followed by a conference call at 4:30 p.m. ET. The call will be accessible via the company’s website and archived for 90 days.
*this image is generated using AI for illustrative purposes only.
Acadia Pharmaceuticals Inc. will announce its second quarter 2026 financial results on August 4, 2026, after the close of the U.S. financial markets. The company’s management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the performance.
The conference call will be available on Acadia’s website under the investors section and will be archived for approximately 90 days. Participants can also register for the call to receive a dial-in number and a unique PIN for access.
Conference Call Details
| Event | Date | Time |
|---|---|---|
| Financial Results Release | August 4, 2026 | After market close |
| Conference Call and Webcast | August 4, 2026 | 4:30 p.m. ET |
Acadia Pharmaceuticals focuses on developing treatments for neurological and rare diseases, including FDA-approved therapies for Parkinson’s disease psychosis and Rett syndrome.
What key performance indicators will investors focus on during the Q2 2026 earnings call?
How might Acadia's pipeline advancements impact its financial outlook for the remainder of 2026?
What market trends in neurological and rare disease treatments could influence Acadia's growth trajectory?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
